The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: TOPIRAMATE.     Injury: Visual field defect     Quarter: 2016Q3

  |<   1/2   << Previous Page   Page 1  

Total Records: 9     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
126627752 TOPIRAMATE. Visual field defect CIPLA 0.00 0 20160818 CN
126682811 TOPIRAMATE. Visual field defect TEVA 48.00 YR F 0 20160819 HK
126688731 TOPIRAMATE. Visual field defect GLENMARK 48.00 YR F 0 20160819 HK
126699393 TOPIRAMATE. Visual field defect RANBAXY 48.00 YR F 0 20160908 HK
126709961 TOPIRAMATE. Visual field defect ACCORD 48.00 YR F 0 20160822 HK
126752191 TOPIRAMATE. Visual field defect ABBVIE 48.00 YR F 0 20160822 COUNTRY NOT SPECIFIED
126763861 TOPIRAMATE. Visual field defect LUPIN 48.00 YR F 0 20160823 HK
126822541 TOPIRAMATE. Visual field defect SANDOZ 48.00 YR F 0 20160824 HK
1001892913 TOPIRAMATE. Visual field defect GLAXOSMITHKLINE 49.90 YR F 74 KG 20160805 US

  |<   1/2   << Previous Page   Page 1  

Total Records: 9     Number of Pages: 1

Execution Time: 0.01511287689209 seconds (ucode:4933124). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.